Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NovaDel, Suda deal

On Dec. 26, 2012, NovaDel said it granted Suda an option to acquire NovaMist sublingual delivery technology and other products.

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE